Chapter/Section Purchase

1 Study Coverage
1.1 Liposomes Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposomes Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposomes Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposomes Drug Delivery Sales Estimates and Forecasts 2017-2028
2.2 Global Liposomes Drug Delivery Revenue Estimates and Forecasts 2017-2028
2.3 Global Liposomes Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Liposomes Drug Delivery Sales by Region
2.4.1 Global Liposomes Drug Delivery Sales by Region (2017-2022)
2.4.2 Global Sales Liposomes Drug Delivery by Region (2023-2028)
2.5 Global Liposomes Drug Delivery Revenue by Region
2.5.1 Global Liposomes Drug Delivery Revenue by Region (2017-2022)
2.5.2 Global Liposomes Drug Delivery Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Liposomes Drug Delivery Sales by Manufacturers
3.1.1 Global Top Liposomes Drug Delivery Manufacturers by Sales (2017-2022)
3.1.2 Global Liposomes Drug Delivery Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liposomes Drug Delivery in 2021
3.2 Global Liposomes Drug Delivery Revenue by Manufacturers
3.2.1 Global Liposomes Drug Delivery Revenue by Manufacturers (2017-2022)
3.2.2 Global Liposomes Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Liposomes Drug Delivery Revenue in 2021
3.3 Global Liposomes Drug Delivery Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Liposomes Drug Delivery Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Liposomes Drug Delivery Sales by Type
4.1.1 Global Liposomes Drug Delivery Historical Sales by Type (2017-2022)
4.1.2 Global Liposomes Drug Delivery Forecasted Sales by Type (2023-2028)
4.1.3 Global Liposomes Drug Delivery Sales Market Share by Type (2017-2028)
4.2 Global Liposomes Drug Delivery Revenue by Type
4.2.1 Global Liposomes Drug Delivery Historical Revenue by Type (2017-2022)
4.2.2 Global Liposomes Drug Delivery Forecasted Revenue by Type (2023-2028)
4.2.3 Global Liposomes Drug Delivery Revenue Market Share by Type (2017-2028)
4.3 Global Liposomes Drug Delivery Price by Type
4.3.1 Global Liposomes Drug Delivery Price by Type (2017-2022)
4.3.2 Global Liposomes Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Liposomes Drug Delivery Sales by Application
5.1.1 Global Liposomes Drug Delivery Historical Sales by Application (2017-2022)
5.1.2 Global Liposomes Drug Delivery Forecasted Sales by Application (2023-2028)
5.1.3 Global Liposomes Drug Delivery Sales Market Share by Application (2017-2028)
5.2 Global Liposomes Drug Delivery Revenue by Application
5.2.1 Global Liposomes Drug Delivery Historical Revenue by Application (2017-2022)
5.2.2 Global Liposomes Drug Delivery Forecasted Revenue by Application (2023-2028)
5.2.3 Global Liposomes Drug Delivery Revenue Market Share by Application (2017-2028)
5.3 Global Liposomes Drug Delivery Price by Application
5.3.1 Global Liposomes Drug Delivery Price by Application (2017-2022)
5.3.2 Global Liposomes Drug Delivery Price Forecast by Application (2023-2028)
6 North America
6.1 North America Liposomes Drug Delivery Market Size by Type
6.1.1 North America Liposomes Drug Delivery Sales by Type (2017-2028)
6.1.2 North America Liposomes Drug Delivery Revenue by Type (2017-2028)
6.2 North America Liposomes Drug Delivery Market Size by Application
6.2.1 North America Liposomes Drug Delivery Sales by Application (2017-2028)
6.2.2 North America Liposomes Drug Delivery Revenue by Application (2017-2028)
6.3 North America Liposomes Drug Delivery Market Size by Country
6.3.1 North America Liposomes Drug Delivery Sales by Country (2017-2028)
6.3.2 North America Liposomes Drug Delivery Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Liposomes Drug Delivery Market Size by Type
7.1.1 Europe Liposomes Drug Delivery Sales by Type (2017-2028)
7.1.2 Europe Liposomes Drug Delivery Revenue by Type (2017-2028)
7.2 Europe Liposomes Drug Delivery Market Size by Application
7.2.1 Europe Liposomes Drug Delivery Sales by Application (2017-2028)
7.2.2 Europe Liposomes Drug Delivery Revenue by Application (2017-2028)
7.3 Europe Liposomes Drug Delivery Market Size by Country
7.3.1 Europe Liposomes Drug Delivery Sales by Country (2017-2028)
7.3.2 Europe Liposomes Drug Delivery Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Liposomes Drug Delivery Market Size by Type
8.1.1 Asia Pacific Liposomes Drug Delivery Sales by Type (2017-2028)
8.1.2 Asia Pacific Liposomes Drug Delivery Revenue by Type (2017-2028)
8.2 Asia Pacific Liposomes Drug Delivery Market Size by Application
8.2.1 Asia Pacific Liposomes Drug Delivery Sales by Application (2017-2028)
8.2.2 Asia Pacific Liposomes Drug Delivery Revenue by Application (2017-2028)
8.3 Asia Pacific Liposomes Drug Delivery Market Size by Region
8.3.1 Asia Pacific Liposomes Drug Delivery Sales by Region (2017-2028)
8.3.2 Asia Pacific Liposomes Drug Delivery Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Liposomes Drug Delivery Market Size by Type
9.1.1 Latin America Liposomes Drug Delivery Sales by Type (2017-2028)
9.1.2 Latin America Liposomes Drug Delivery Revenue by Type (2017-2028)
9.2 Latin America Liposomes Drug Delivery Market Size by Application
9.2.1 Latin America Liposomes Drug Delivery Sales by Application (2017-2028)
9.2.2 Latin America Liposomes Drug Delivery Revenue by Application (2017-2028)
9.3 Latin America Liposomes Drug Delivery Market Size by Country
9.3.1 Latin America Liposomes Drug Delivery Sales by Country (2017-2028)
9.3.2 Latin America Liposomes Drug Delivery Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Liposomes Drug Delivery Market Size by Type
10.1.1 Middle East and Africa Liposomes Drug Delivery Sales by Type (2017-2028)
10.1.2 Middle East and Africa Liposomes Drug Delivery Revenue by Type (2017-2028)
10.2 Middle East and Africa Liposomes Drug Delivery Market Size by Application
10.2.1 Middle East and Africa Liposomes Drug Delivery Sales by Application (2017-2028)
10.2.2 Middle East and Africa Liposomes Drug Delivery Revenue by Application (2017-2028)
10.3 Middle East and Africa Liposomes Drug Delivery Market Size by Country
10.3.1 Middle East and Africa Liposomes Drug Delivery Sales by Country (2017-2028)
10.3.2 Middle East and Africa Liposomes Drug Delivery Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Corporation Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Gilead Sciences Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences Recent Developments
11.3 Pacira
11.3.1 Pacira Corporation Information
11.3.2 Pacira Overview
11.3.3 Pacira Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pacira Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pacira Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Overview
11.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sun Pharmaceutical Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceutical Recent Developments
11.5 Luye Pharma
11.5.1 Luye Pharma Corporation Information
11.5.2 Luye Pharma Overview
11.5.3 Luye Pharma Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Luye Pharma Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Luye Pharma Recent Developments
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Corporation Information
11.6.2 Sigma-Tau Group Overview
11.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sigma-Tau Group Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sigma-Tau Group Recent Developments
11.7 Fudan-Zhangjiang
11.7.1 Fudan-Zhangjiang Corporation Information
11.7.2 Fudan-Zhangjiang Overview
11.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fudan-Zhangjiang Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Corporation Information
11.8.2 Teva Pharmaceutical Overview
11.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Teva Pharmaceutical Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Recent Developments
11.9 CSPC
11.9.1 CSPC Corporation Information
11.9.2 CSPC Overview
11.9.3 CSPC Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 CSPC Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CSPC Recent Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Overview
11.10.3 Novartis Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Kingond Pharm
11.11.1 Kingond Pharm Corporation Information
11.11.2 Kingond Pharm Overview
11.11.3 Kingond Pharm Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Kingond Pharm Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Kingond Pharm Recent Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Corporation Information
11.12.2 Spectrum Pharmaceuticals Overview
11.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Spectrum Pharmaceuticals Recent Developments
11.13 Shanghai New Asia
11.13.1 Shanghai New Asia Corporation Information
11.13.2 Shanghai New Asia Overview
11.13.3 Shanghai New Asia Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shanghai New Asia Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shanghai New Asia Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Liposomes Drug Delivery Industry Chain Analysis
12.2 Liposomes Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liposomes Drug Delivery Production Mode & Process
12.4 Liposomes Drug Delivery Sales and Marketing
12.4.1 Liposomes Drug Delivery Sales Channels
12.4.2 Liposomes Drug Delivery Distributors
12.5 Liposomes Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Liposomes Drug Delivery Industry Trends
13.2 Liposomes Drug Delivery Market Drivers
13.3 Liposomes Drug Delivery Market Challenges
13.4 Liposomes Drug Delivery Market Restraints
14 Key Findings in The Global Liposomes Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer